Thermo Fisher Scientific Inc. (TMO) financial statements and ratios from SEC XBRL: revenue $44.56B (TTM), net margin 15.0%, revenue growth 10.5% YoY, P/E 33.5. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $44.56B |
| Net Margin | 15.0% |
| Revenue Growth (YoY) | 10.5% |
| EPS Growth (YoY) | 9.3% |
| FCF Growth (YoY) | 51.6% |
| P/E Ratio | 33.5 |
| EV / EBITDA | 29.5 |
| Price / Book | 4.43 |
| Price / Sales | 5.03 |
| FCF Yield | 3.1% |
| DCF Value (model) | $98.53 |
| DCF Upside vs Price | -84.3% |
| Altman Z-Score | 3.99 (safe) |
| Sector P/E (Technology) | 33.9 |
TMO overview · TMO earnings · TMO KPIs · TMO investor relations · TMO ownership · TMO peers · TMO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.